Home NDC 69800-6503-01 NDC 69800-6503-01 - BIVIGAM This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
Product NDC 69800-6503
Requested NDC 69800-6503-01
Package NDCs from labels 69800-6503-2, 69800-6503-1, 69800-6503-01
Manufacturer ADMA Biologics, Inc.
Effective date 2026-09-29
Current FDA listing Not matched in FDA.report NDC product tables DailyMed Labels# Label, Manufacturer, Effective date table Label Manufacturer Effective date Type BIVIGAM - ADMA Biologics, Inc. ADMA Biologics, Inc. 2026-09-29 HUMAN PRESCRIPTION DRUG LABEL
DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 69800-6503-1 BIVIGAM 1 in 1 CARTON INJECTION, SOLUTION 1 15 69800-6503-2 BIVIGAM 100 mL in 1 VIAL, SINGLE-USE INJECTION, SOLUTION 100 15
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 69800-6503 BIVIGAM (IMMUNE GLOBULIN INTRAVENOUS (HUMAN) 10%) INJECTION, SOLUTION [ADMA BIOLOGICS, INC.] 15 Current NDC, Legacy NDC, 2 package rows 20250507_a2244aa0-a6d0-11df-b385-0002a5d5c51b.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 2 of 2 · 21 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join Cutaquig IMMUNOGLOBULIN G Octapharma USA Inc f3de095f-791a-85dc-7a14-ec7790cb13aa 2021-11-30 Boxed warning, Warnings, Adverse reactions Exact identifier unii: 66Y330CJHS
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.